Literature DB >> 4009064

Inhibition of cerebroside synthesis in the brains of mice treated with L-cycloserine.

K S Sundaram, M Lev.   

Abstract

Subcutaneous injection of L-cycloserine resulted in a 28% reduction in cerebroside levels in mouse brain but had no effect on the levels of gangliosides. In contrast, intraperitoneal injection results in a reduction of ganglioside as well as cerebroside + sulfatide levels. The route of injection influenced the degree of 3-ketodihydrosphingosine synthase inhibition. Intraperitoneal injection caused a rapid decrease in synthase activity followed by recovery over 48 hr, whereas subcutaneous injection resulted in no inhibition over this time; only after daily injection for a week was synthase activity reduced 35%. One week following cessation of L-cycloserine administration, enzyme activity had recovered, whereas the cerebroside level continued to fall. All lipids and enzymes showed normal levels 3 weeks post-cycloserine administration. L-[3H]serine incorporation into glycolipids showed that cerebroside synthesis was most affected, whereas sulfatide synthesis was less affected. One week after cessation of cycloserine treatment, cerebroside synthesis was still severely inhibited, whereas sulfatide levels were near normal. Two weeks after cessation of L-cycloserine administration, synthesis of these glycolipids was similar to that of controls.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009064

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Inhibition of the PLP-dependent enzyme serine palmitoyltransferase by cycloserine: evidence for a novel decarboxylative mechanism of inactivation.

Authors:  Jonathan Lowther; Beverley A Yard; Kenneth A Johnson; Lester G Carter; Venugopal T Bhat; Marine C C Raman; David J Clarke; Britta Ramakers; Stephen A McMahon; James H Naismith; Dominic J Campopiano
Journal:  Mol Biosyst       Date:  2010-05-05

2.  Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.

Authors:  Jacqueline A Hawkins-Salsbury; Lauren Shea; Xuntian Jiang; Daniel A Hunter; A Miguel Guzman; Adarsh S Reddy; Elizabeth Y Qin; Yedda Li; Steven J Gray; Daniel S Ory; Mark S Sands
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

3.  Cycloserine-induced decrease of cerebroside in myelin.

Authors:  S L Miller; L Denisova
Journal:  Lipids       Date:  1998-04       Impact factor: 1.880

4.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

5.  The long-term administration of L-cycloserine to mice: specific reduction of cerebroside level.

Authors:  K S Sundaram; M Lev
Journal:  Neurochem Res       Date:  1989-03       Impact factor: 3.996

6.  The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts.

Authors:  P Leppimäki; R Kronqvist; J P Slotte
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

7.  Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.

Authors:  Gregory J Heller; Michael S Marshall; Yazan Issa; Jeffrey N Marshall; Duc Nguyen; Emily Rue; Koralege C Pathmasiri; Miriam S Domowicz; Richard B van Breemen; Leon M Tai; Stephanie M Cologna; Stephen J Crocker; Maria I Givogri; Mark S Sands; Ernesto R Bongarzone
Journal:  Mol Ther       Date:  2021-01-26       Impact factor: 11.454

8.  Inhibition of ceramide accumulation in AdipoR1-/- mice increases photoreceptor survival and improves vision.

Authors:  Dominik Lewandowski; Andrzej T Foik; Roman Smidak; Elliot H Choi; Jianye Zhang; Thanh Hoang; Aleksander Tworak; Susie Suh; Henri Leinonen; Zhiqian Dong; Antonio Fm Pinto; Emily Tom; Jennings Luu; Joan Lee; Xiuli Ma; Erhard Bieberich; Seth Blackshaw; Alan Saghatelian; David C Lyon; Dorota Skowronska-Krawczyk; Marcin Tabaka; Krzysztof Palczewski
Journal:  JCI Insight       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.